Top Smart Score Stocks
Analysts' Top Stocks
Insiders' Hot Stocks
Daily Stock Ratings
Daily Insider Transactions
My Portfolio Analysis
My Public Profile
Find & Follow Experts
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
Ideas & Insights
Calendars & Events
Stock Market Holidays
Plans & Pricing
Vaxart Stock Takes a Hit, but Is It Warranted? Analyst Weighs In
Over the past week, investors optimistically pushed Vaxart’s (VXRT) share price up by over 100%. High short-interest and...
Feb 04, 2021
Vaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data; Street Says Buy
Shares of Vaxart cratered 58% on Feb. 3 after early preliminary trial data showed that its oral COVID-19...
Feb 04, 2021
Analysts Pound the Table on This ‘Strong Buy’ Coronavirus Stock
A journey of a thousand miles begins with a single step, and a big one in this case....
Nov 16, 2020
Vaxart: An Alternative Opportunity in the COVID-19 Vaccine Landscape
On Tuesday, vaccine specialist Vaxart (VXRT) announced it has dosed the first subject in the Phase 1 study...
Oct 17, 2020
Kindred Spikes 12% On Vaxart Vaccine Manufacturing Deal
Shares in Kindred Biosciences are jumping 12% after the company announced an expanded manufacturing agreement for Vaxart’s oral...
Oct 07, 2020
Vaxart: Watch Out for This Underdog in the COVID-19 Vaccine Race
First mover advantage is not to be sniffed at. However, history is littered with first movers being usurped...
Sep 23, 2020
Vaxart Can Still Be a Major Force in the COVID-19 Vaccine Landscape, Says Analyst
Vaxart (VXRT) began the week with a monster Monday session. Shares of the vaccine specialist surged by 47%...
Sep 16, 2020
Take Advantage of Vaxart’s Sharp Pullback, Says Analyst
The recent news of an adverse reaction suffered by a participant in AstraZeneca’s Covid-19 vaccine candidate’s clinical trial...
Sep 10, 2020
Vaxart Positioned to Further Advance Oral COVID-19 Vaccine; Analyst Says ‘Buy’
In the race to develop a COVID-19 vaccine, the contenders aren’t about to cross the finish line just...
Aug 13, 2020
Vaxart’s (VXRT) Stock Will Surge 130% From Current Levels, Says Analyst
Vaccine specialist Vaxart (VXRT) reported 2Q20 earnings last week, but since its vaccine candidates are all in development,...
Aug 10, 2020
Buy This Coronavirus Stock on Weakness, Says 5-Star Analyst
COVID-19 has put several little-known pharma companies on the map. Going hand in hand with these nano-caps’ pursuit...
Jul 30, 2020
Vaxart: No Midnight Bells Ringing Yet for This Cinderella Biotech Story
It has been a breakout year for vaccine specialist Vaxart (VXRT). Entering 2020, the company had a market...
Jul 15, 2020
Vaxart Explodes 96%- And Rallies After-Hours- On Covid-19 Deal
Shares in Vaxart (VXRT) exploded by 96% in Thursday’s trading, and continued to rally a further 27% after-hours,...
Jun 26, 2020